Borrelia burgdorferi IgG ELISA

Enzyme immunoassay for the qualitative determination of IgG class antibodies against Borrelia burgdorferi in human serum, plasma and CSF.

INTENDED USE:The Borrelia burgdorferi IgG ELISA is intended for the qualitative determination of IgG class antibodies against Borrelia burgdorferi in human serum, plasma (citrate, heparin) and CSF (cerebrospinal fluid). For the determination of intrathecally produced IgG antibodies, separate instructions for use for CSF (DEBORL0400) can be obtained from the manufacturer.

GENERAL INFORMATION:The qualitative immunoenzymatic determination of specific antibodies is based on the ELISA (Enzymelinked Immunosorbent Assay) technique. Microtiterplates are coated with specific antigens to bind corresponding antibodies of the sample. After washing the wells to remove all unbound sample material a horseradish peroxidase (HRP) labelled conjugate is added. This conjugate binds to the captured antibodies. In a second washing step unbound conjugate is removed. The immune complex formed by the bound conjugate is visualized by adding Tetramethylbenzidine (TMB) substrate which gives a blue reaction product. The intensity of this product is proportional to the amount of specific antibodies in the sample. Sulphuric acid is added to stop the reaction. This produces a yellow endpoint colour. Absorbance at 450/620 nm is read using an ELISA Microtiterplate reader.

KIT CHARACTERISTICS:
- Method: ELISA
- Tests: 96
- Incubation Time / Conditions: 1 h (37°C), 30 min (RT), 15 min (RT/dark)
- Standard Range: Cut-off
- Sensitivity analytical: diagn. 98.39 %
- Final Sample Volume: 100 µl
- Sample Type: serum, plasma (citrate, heparin), CSF
- Sample Pretreatment: 1:101 diluted
- Isotope / Substrate: TMB 450 nm
- Regulatory Status: CE/RUO